This inventor holds 1 USPTO granted patent. Top assignee: Via Pharmaceuticals, Inc.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Emmanuelle Limanton: Innovator in PDE2 Inhibitors
Introduction
Emmanuelle Limanton is a notable inventor based in Hochstatt, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific neurological conditions. Her work focuses on innovative therapeutic methods that can improve patient outcomes.
Latest Patents
Emmanuelle Limanton holds a patent for "Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof." This invention relates to compounds that exhibit PDE2 inhibitory activities. The therapeutic methods involve administering these compounds to treat various diseases affecting the central or peripheral nervous system. Additionally, her patent includes pharmaceutical compositions that comprise these compounds and outlines methods for their preparation.
Career Highlights
Emmanuelle is currently associated with Via Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has the potential to lead to new treatments that can significantly impact the lives of individuals suffering from neurological disorders.
Collaborations
Emmanuelle collaborates with esteemed colleagues such as Patrick Wagner and Stefano Biondi. Their combined expertise enhances the research and development processes within their projects.
Conclusion
Emmanuelle Limanton's innovative work in the field of PDE2 inhibitors showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options in treating neurological diseases.